drugset / Trial / NCT02273843

A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis

NCT02273843

Phase 1 Completed 50 enrolled Mansoura University Children Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized controlled trial (RCT) to evaluate the influence of different doses of vitamin D3 (800 IU/d versus 400 IU/d), on serum levels of interleukin (IL)-6, TNF-alpha and C- reactive (CRP) in premature infants with clinical evidence of late-onset sepsis and to assess its influence on clinical outcomes of these infants.

Timeline

Start
2013-09
Primary completion
2015-08
Completion
2015-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 400 iu Oral
Comparator Cholecalciferol Other / unclassified 800 iu Oral

Indications